Ethical Standards

Jazz Pharmaceuticals has established various methods of confidential communications. We encourage anyone, whether working for Jazz or not, to speak-up about potential violations of our code of conduct or other company policies, or any suspected violations of laws and regulations. You may report a potential ethics violation or concern by contacting the I-CARE Speak-up Helpline in North America by phone at 800-511-2034 or through an online webform by clicking here.

Please note that if you are reporting from outside of North America, you can find up-to-date local phone numbers for most countries, where available by clicking here and choosing the telephone option. Translations services are available in most languages.

Anonymous reporting is available, but we encourage anonymous reporters to engage in the process to answer questions we may have after receiving your report by creating a username and password. Log back into the system to receive updates on the status of your report and communication.

Wherever you are in the world, you also have the option to report an ethics violation/concern by sending an email directly to the Chief Compliance and Ethics Officer or through postal mail:

Jazz Pharmaceuticals        
Attn: Chief Compliance and Ethics Officer or Chief Legal Officer        
3170 Porter Drive        
Palo Alto, CA 94304 USA

Compliance with applicable laws, rules and regulations in the countries where we do business is an overriding principle of Jazz Pharmaceuticals’ corporate culture. The company’s commitment to ethical behavior is implemented through comprehensive compliance policies, employee training and monitoring programs and an open-door policy for reporting suspected violations. Read more about our Compliance Program below.

 Comprehensive Compliance Program 

As part of Jazz Pharmaceuticals’ continuing commitment to corporate compliance, Jazz Pharmaceuticals declares that, to the best of its knowledge, and based on a good faith understanding of the statutory requirements of California Health and Safety Code § 119400 and 119402, it has adopted a Comprehensive Compliance Program as mandated by this California law. To the best of our knowledge, as of July 1, 2023, Jazz Pharmaceuticals believes that it is in compliance with its Comprehensive Compliance Program and its good faith understanding of the requirements of California Health and Safety Code § 119400 and 119402.

For questions about our Comprehensive Compliance Program or to obtain a copy, please contact us at compliance@jazzpharma.com.

Acting with integrity is integral to our ability to realize our unique mission of innovating to transform patients’ lives and bring potentially life-changing medicines to those that need them. The Code of Conduct and Ethics (“Code”) is the foundation for our most important guiding principles of how we conduct our daily work. It provides important guidance and direction and describes our commitment to each other and those we serve. We also expect those with whom we do business will adhere to the Code when performing services for Jazz.

Code of Conduct (English Version)                        
Code of Conduct (Italian Version)

Jazz is committed to comply with applicable anti-corruption and anti-bribery laws, including the Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act (UKBA). To help ensure compliance with these laws, Jazz has adopted a global Anti-Corruption Policy that applies to all employees of the company, its subsidiaries and affiliates, and third party vendors and other agents acting on our behalf.

 Anti-Corruption Policy

Slavery and Human Trafficking Statement – 2023                
Jazz Pharmaceuticals plc and its subsidiaries (“Jazz” or “the Company”) are committed to operating our global business with integrity and upholding a high level of ethical conduct among our employees and business partners. We expect that suppliers which provide materials for use in our tangible goods for sale (“Product Suppliers”) to adopt sound human rights practices, to treat workers fairly, with dignity and respect and in all cases to eliminate human trafficking and slavery in their workplace.

Verification: Jazz has existing procedures for assessing our Product Suppliers which include steps for evaluating whether our Product Suppliers comply with applicable laws related to eradication of human trafficking, slavery and illegal child labor. Our Procurement, Supply Chain and Quality Assurance teams oversee these verification procedures. In addition, Jazz has adopted written Standards of Conduct for Supply Chain and will request that our Product Suppliers certify that they comply with applicable laws concerning human trafficking, slavery and illegal child labor in the countries in which they do business.

Audits: Jazz conducts regular, periodic audits of its Product Suppliers to evaluate their compliance with Jazz policies and applicable legal and regulatory requirements. Jazz typically conducts these audits using its own personnel, although it reserves the right to engage independent third-party auditors. Jazz’s current Contract Manufacturer Assessment Guidelines establish procedures for audits of current and potential Product Suppliers, including their training, experience and qualifications, adherence to legal and regulatory requirements, and evaluation of the suppliers’ compliance with quality systems. Jazz tracks any observations and/or non-compliance in its Audit Follow Up & Close-Out procedures to ensure that instances of non-compliance are properly remediated. Jazz has updated its Contract Manufacturer Assessment Guidelines to expressly address human trafficking, slavery and illegal child labor in its auditing protocol.

Materials: Jazz has implemented procedures that require Product Suppliers to certify that materials incorporated into Jazz’s products comply with the laws regarding human trafficking, slavery and illegal child labor in applicable countries.

Accountability Standards: Jazz has established internal accountability standards and procedures, including disciplinary action for its employees and contractors with procurement responsibilities who fail to meet Jazz’s standards regarding identification and elimination of human trafficking, slavery and illegal child labor in its supply chain.

Training: Jazz conducts training for its employees and management who have direct responsibility for supply chain management, particularly with respect to mitigation risks of human trafficking, slavery and illegal child labor within the supply chain.

  Slavery and Human Trafficking Statement

Jazz Pharmaceuticals is committed to compliance with tax law and practice globally. We understand that we have a responsibility to pay the appropriate amount of tax in each jurisdiction in which we operate. At the same time, we seek to balance this with our responsibility to our shareholders to deliver value by structuring our tax affairs in a tax efficient manner.

Jazz Pharmaceuticals has prepared and published its tax strategy in compliance with Schedule 19 to the UK Finance Act 2016.

Jazz Pharmaceuticals Tax Strategy

2023 France Gender Equality Index

UK Gender Pay Report 2023